NCT07573969 Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral Surgeries
| NCT ID | NCT07573969 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Ain Shams University |
| Condition | Perioperative Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2026-05 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 72 participants in total. It began in 2026-05 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effect of adding dexmedetomidine to bupivacaine compared to ketamine in the caudal block on perioperative analgesia in patients undergoing lumbosacral surgeries under general anesthesia.
Eligibility Criteria
Inclusion Criteria: * Age 21-60 years. * Sex: Both sexes. * American Society of Anesthesiologists (ASA) Physical Status Class-I and II. * Scheduled for lumbosacral surgery under General Anesthesia. Exclusion Criteria: * Declining to give written informed consent or patients with significant cognitive dysfunction that hinders informed consent. * History of allergy to the medications used in the study. * Contraindications to regional anesthesia (including coagulopathy and local infection). * History of recent analgesic intake or abuse. * Pregnancy or lactating mothers.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07573969 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 60 Years, studying Perioperative Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07573969 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 72 participants.
Is NCT07573969 currently recruiting?
Yes, NCT07573969 is actively recruiting participants. Contact the research team at Salmaaymen0103389@med.asu.edu.eg for enrollment information.
Where is the NCT07573969 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07573969 clinical trial?
NCT07573969 is sponsored by Ain Shams University. The trial plans to enroll 72 participants.